COVID-19 Therapeutic Alert: antivirals or neutralising antibodies for non-hospitalised patients with COVID-19

The published policy has been updated, effective from 13 June 2022, to link to the published report of the Independent Advisory Group commissioned by the DHSC to advise on the groups of patients likely to be at highest risk of deterioration, hospitalisation or death from a COVID infection.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in

Sorry, we need to confirm your details before you can access this content.

If you have just signed up to OnMedica, you are seeing this message because we couldn’t automatically verify that you are a practising doctor in the UK. Please check your email inbox as we may need a few more details to validate your OnMedica membership. If you haven’t received an email from us or you need assistance, please contact